The results of its eight-week consumption in 66 NAFLD patients showed that soy milk consumption (240 ml per day) could significantly diminish the level of serum insulin (p=0.04), homeostasis model assessment of insulin resistance (p=0.03), and blood pressure (p=0.04). Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.